Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017, Article ID 1323802, 8 pages
https://doi.org/10.1155/2017/1323802
Research Article

Analytical Interference by Contrast Agents in Biochemical Assays

1Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Department of Clinical Biochemistry, Copenhagen University Hospital Herlev, Herlev, Denmark
3Department of Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark

Correspondence should be addressed to Henrik S. Thomsen; kd.hnoiger@nesmoht.kirneh

Received 5 January 2017; Accepted 30 March 2017; Published 10 April 2017

Academic Editor: Giuseppe Rubini

Copyright © 2017 Sigrid Otnes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lippi, M. Daves, and C. Mattiuzzi, “Interference of medical contrast media on laboratory testing,” Biochemia Medica, vol. 24, no. 1, pp. 80–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Brown, M. R. Hynes, and J. H. Wible Jr., “Measurement of serum calcium concentration after administration of four gadolinium-based contrast agents to human volunteers,” American Journal of Roentgenology, vol. 189, no. 6, pp. 1539–1544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Doorenbos, A. Ozyilmaz, and M. Van Wijnen, “Severe pseudohypocalcemia after gadolinium-enhanced magnetic resonance angiography,” New England Journal of Medicine, vol. 349, no. 8, pp. 817–818, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Gandhi, V. R. Narra, J. J. Brown et al., “Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference,” American Journal of Roentgenology, vol. 190, no. 3, pp. W213–W217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Junge and B. Troge, “Kontrastmittel als störfaktoren in der laborchemischen analytik,” in Röntgenkontrastmittel, P. E. Peters and E. Zeitler, Eds., pp. 76–82, Springer, Berlin, Germany, 1991. View at Google Scholar
  6. H. P. Kang, M. G. Scott, B. N. Joe, V. Narra, J. Heiken, and C. A. Parvin, “Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method,” Clinical Chemistry, vol. 50, no. 4, pp. 741–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lin, J.-M. Idee, M. Port et al., “Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 5, pp. 931–943, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Löwe, T. Balzer, and U. Hirt, “Interference of gadolinium-containing contrast-enhancing agents with colorimetric calcium laboratory testing,” Investigative Radiology, vol. 40, no. 8, pp. 521–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Löwe, J. Breuer, and P. Palkowitsch, “Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma,” Investigative Radiology, vol. 46, no. 6, pp. 366–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. T. Normann, A. Frøysa, and M. Svaland, “Interference of gadodiamide injection (OMNISCAN® on the colorimetric determination of serum calcium,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 55, no. 5, pp. 421–426, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Prince, H. E. Erel, R. W. Lent et al., “Gadodiamide administration causes spurious hypocalcemia,” Radiology, vol. 227, no. 3, pp. 639–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. A. S. Proctor, L. V. Rao, and W. L. Roberts, “Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays,” American Journal of Clinical Pathology, vol. 121, no. 2, pp. 282–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. H. L. Zhang, H. Ersoy, and M. R. Prince, “Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements,” Journal of Magnetic Resonance Imaging, vol. 23, no. 3, pp. 383–387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Frenzel, P. Lengsfeld, H. Schirmer, J. Hütter, and H.-J. Weinmann, “Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37°C,” Investigative Radiology, vol. 43, no. 12, pp. 817–828, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Fretellier, N. Poteau, C. Factor et al., “Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents,” Investigative Radiology, vol. 49, pp. 766–772, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-M. Idée, M. Port, I. Raynal, M. Schaefer, S. Le Greneur, and C. Corot, “Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review,” Fundamental and Clinical Pharmacology, vol. 20, no. 6, pp. 563–576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Corot, J.-M. Idee, A.-M. Hentsch et al., “Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme,” Journal of Magnetic Resonance Imaging, vol. 8, no. 3, pp. 695–702, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Haylor, M. E. Vickers, and S. K. Morcos, “Interference of gadolinium-based contrast agents with the measurement of serum creatinine by the Jaffe reaction,” British Journal of Radiology, vol. 82, no. 977, pp. 438–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-T. Lin, H.-C. Lee, W.-C. Voon et al., “Positive interference from contrast media in cardiac troponin I immunoassays,” Kaohsiung Journal of Medical Sciences, vol. 22, no. 3, pp. 107–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. K. Morcos, H. S. Thomsen, and C. M. Exley, “Contrast media: interactions with other drugs and clinical tests,” European Radiology, vol. 15, no. 7, pp. 1463–1468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. P. Niendorf and W. Seifert, “Serum iron and serum bilirubin after administration of Gd-DTPA-dimeglumine: a pharmacologic study in healthy volunteers,” Investigative Radiology, vol. 23, supplement 1, pp. S275–S280, 1988. View at Google Scholar · View at Scopus
  22. X. Bossuyt, “Interferences in clinical capillary zone electrophoresis of serum proteins,” Electrophoresis, vol. 25, no. 10-11, pp. 1485–1487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Vermeersch, G. Mariën, and X. Bossuyt, “Pseudoparaproteinemia related to Iomeprol administration after angiocardiography: detection in the β fraction by capillary zone electrophoresis,” Clinical Chemistry, vol. 52, no. 12, pp. 2312–2313, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Arranz-Pena, M. Gonzalez-Sagrado, A. M. Olmos-Linares, N. Fernandez-Garcia, and F. Javier Martin-Gil, “Interference of iodinated contrast media in serum capillary zone electrophoresis,” Clinical Chemistry, vol. 46, no. 5, pp. 736–737, 2000. View at Google Scholar · View at Scopus
  25. X. Bossuyt, A. Mewis, and N. Blanckaert, “Interference of radio-opaque agents in clinical capillary zone electrophoresis,” Clinical Chemistry, vol. 45, no. 1, pp. 129–131, 1999. View at Google Scholar · View at Scopus
  26. G. van der Watt and P. Berman, “Pseudoparaproteinemia after Iopamidol infusion for coronary angiography,” Clinical Chemistry, vol. 51, no. 1, pp. 273–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Hayakawa, Y. Okuno, K. Fujiwara, and Y. Shimizu, “Effect of iodinated contrast media on ionic calcium,” Acta Radiologica, vol. 35, no. 1, pp. 83–87, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Thomsen and J. A. W. Webb, Eds., Contrast Media, Safety Issues and ESUR Guidelines, Springer, Berlin, Germany, 3rd edition, 2014.
  29. S. F. Williams, S. E. Meek, and T. J. Moraghan, “Spurious hypocalcemia after gadodiamide administration,” Mayo Clinic Proceedings, vol. 80, no. 12, pp. 1655–1657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. A. Wilkins, J. R. Whittington, G. S. Brigden, A. Lahiri, M. E. Heber, and L. O. Hughes, “Safety and pharmacokinetics of ioversol in healthy volunteers,” Investigative Radiology, vol. 24, no. 10, pp. 781–788, 1989. View at Publisher · View at Google Scholar · View at Scopus
  31. Greiner bio-one international.com [Internet], Kremsmünster, Austria: Greiner Bio-One International. Vacuette blood collection tubes, https://shop.gbo.com/en/row/articles/catalogue/articles/0010_0010/.
  32. “Technical Documents-Instructions for use [Internet],” Buckinghamshire: Ortho Clinical Diagnostics, 2014, http://apps.orthoclinical.com//TechDocs/TechDocSearch.aspx?culture=en-jj&tID=0.
  33. “KonelabTM PRIME 60i with ISE unit [Internet],” Waltham, Mass, USA: Thermo Fischer Scientific, 2015, http://www.thermoscientific.com/en/product/konelab-prime-60-clinical-chemistryanalyzer.html.
  34. ADVIA 2120, “ADVIA 2120i Hematology Systems, Operator's Guide [Internet],” Dublin, Ireland: Siemens Healthcare Diagnostics; 2011, https://www.healthcare.siemens.com/services/laboratory-diagnostics/service-and-support/technical-documentation.
  35. The R Foundation, “The R Project for Statistical Computing,” The R Foundation, https://www.r-project.org/.
  36. C. Ricós, V. Alvarez, F. Cava et al., “Current databases on biological variation: pros, cons and progress,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 59, no. 7, pp. 491–500, 2009. View at Publisher · View at Google Scholar
  37. L. E. Mallette and L. S. Gomez, “Systemic hypocalcemia after clinical injections of radiographic contrast media: amelioration by omission of calcium chelating agents,” Radiology, vol. 147, no. 3, pp. 677–679, 1983. View at Publisher · View at Google Scholar · View at Scopus
  38. D. K. Murdock, J. Walsh, D. E. Euler, G. Kozeny, and P. J. Scanlon, “Inotropic effects of ionic contrast media: the role of calcium binding additives,” Catheterization and Cardiovascular Diagnosis, vol. 10, no. 5, pp. 455–463, 1984. View at Publisher · View at Google Scholar · View at Scopus
  39. N. P. Jørgensen, J. Ø. Nossen, K. W. Borch et al., “Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media,” European Journal of Radiology, vol. 15, no. 3, pp. 252–257, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. C. R. Becker, A. Vanzulli, C. Fink et al., “Multicenter comparison of high concentration contrast agent iomeprol-400 with iso-osmolar iodixanol-320: contrast enhancement and heart rate variation in coronary dual-source computed tomographic angiography,” Investigative Radiology, vol. 46, no. 7, pp. 457–464, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Manninen, K. Tahvanainen, K. W. Borch et al., “Iodixanol, a new non-ionic, dimeric contrast medium in cardioangiography: a double-masked, parallel comparison with iopromide,” European Radiology, vol. 5, no. 4, pp. 364–370, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Rabiet, M. Letouzet, S. Hassanzadeh, and S. Simon, “Transmetallation of Gd-DTPA by Fe3+, Cu2+ and Zn2+ in water: batch experiments and coagulation-flocculation simulations,” Chemosphere, vol. 95, pp. 639–642, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. P. L. Choyke and M. V. Knopp, “Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale,” Radiology, vol. 227, no. 3, pp. 627–628, 2003. View at Publisher · View at Google Scholar · View at Scopus